WHO on Cough Syrup Deaths: In many countries including Uzbekistan, the case of death of children allegedly due to drinking cough syrup is still in headlines. The World Health Organization has once again warned about its use. The World Health Organization has appealed to the countries of the world to take immediate action in this regard after the cough syrup deaths. Along with this, the global organization has also issued a Global Medical Alert.
Last year in 2022, 19 children died in Uzbekistan allegedly after drinking Indian cough syrup. Death was said to have occurred due to the consumption of two cough syrups made by Noida-based company Marion Biotech.
WHO strict about cough syrup
The World Health Organization (WHO) has urged for immediate and concrete action against such deadly drugs. WHO’s strict attitude has come in the year 2022 after the deaths of children due to cough syrup in many countries including Uzbekistan. The WHO said on Monday that more than 300 children under the age of 5 died in Gambia, Indonesia and Uzbekistan from contaminated medicines.
urgent action appeal
High levels of diethylene glycol and ethylene glycol were found in cough syrup. The UN health agency also said that the Philippines, Timor Leste, Senegal and Cambodia could potentially be affected as they may also have such drugs for sale. WHO says that since these are not isolated incidents, the organization appeals to various key stakeholders engaged in medical supplies to take immediate action.
WHO gave instructions
The World Health Organization has appealed to countries around the world to detect and remove any substandard medical products from their respective markets. The global body has also been asked to ensure that all medical products in their respective markets are approved for sale by the competent authorities. It has also been said to provide appropriate resources for inspection and improvement of construction sites within its jurisdiction as per international norms and standards.
Along with this, WHO has appealed to implement appropriate laws to help deal with the manufacture, distribution or use of substandard and counterfeit medicines.
read this also:
